XMH

4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]-2-PIPERAZINECARBOXYLIC ACID ETHYL ESTER

Created:	2001-07-25
Last modified:	2011-06-04

Find Related PDB Entry
1 entries where XMH is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	71
Chiral Atom Count	1
Bond Count	75
Aromatic Bond Count	17

2D diagram of XMH

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	4-[(6-CHLORO-2-NAPHTHALENYL)SULFONYL]-1-[[1-(4-PYRIDINYL)-4-PIPERIDINYL]METHYL]-2-PIPERAZINECARBOXYLIC ACID ETHYL ESTER
Systematic Name (OpenEye OEToolkits)	ethyl (1S,2R,4S)-4-(6-chloronaphthalen-2-yl)sulfonyl-1-[(1-pyridin-4-ylpiperidin-4-yl)methyl]piperazine-2-carboxylate
Formula	C₂₈ H₃₃ Cl N₄ O₄ S
Molecular Weight	557.104
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	10.04	Clc2ccc1cc(ccc1c2)S(=O)(=O)N5CC(C(=O)OCC)N(CC4CCN(c3ccncc3)CC4)CC5
SMILES	CACTVS	3.341	CCOC(=O)[CH]1CN(CCN1CC2CCN(CC2)c3ccncc3)[S](=O)(=O)c4ccc5cc(Cl)ccc5c4
SMILES	OpenEye OEToolkits	1.5.0	CCOC(=O)C1CN(CCN1CC2CCN(CC2)c3ccncc3)S(=O)(=O)c4ccc5cc(ccc5c4)Cl
Canonical SMILES	CACTVS	3.341	CCOC(=O)[C@H]1CN(CCN1CC2CCN(CC2)c3ccncc3)[S](=O)(=O)c4ccc5cc(Cl)ccc5c4
Canonical SMILES	OpenEye OEToolkits	1.5.0	CCOC(=O)[C@H]1C[N@](CC[N@@]1CC2CCN(CC2)c3ccncc3)S(=O)(=O)c4ccc5cc(ccc5c4)Cl
InChI	InChI	1.03	InChI=1S/C28H33ClN4O4S/c1-2-37-28(34)27-20-33(38(35,36)26-6-4-22-17-24(29)5-3-23(22)18-26)16-15-32(27)19-21-9-13-31(14-10-21)25-7-11-30-12-8-25/h3-8,11-12,17-18,21,27H,2,9-10,13-16,19-20H2,1H3/t27-/m1/s1
InChIKey	InChI	1.03	KTOZABIXRDAUJO-HHHXNRCGSA-N

Related Resource References

Resource Name	Reference
PubChem	446343

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.